You are currently viewing a new version of our website. To view the old version click .

Antimicrobial Drug Delivery for the Treatment of Highly Prevalent Infections

Special Issue Information

Dear Colleagues,

Microbial infections, whether bacterial or viral, can be very challenging to treat, in many cases resulting in the development of antibacterial/antiviral resistance against existing drugs. The increase in bacterial and viral resistance to standard-of-care drugs poses a serious challenge to existing treatment methodologies. In recent years, there have been multiple advances in medicinal chemistry, genomic, transcriptomic and proteomic profiling which have led to the development of novel therapeutics that target bacteria and viruses through novel modes of action previously unknown to humankind. Hence, in this Special Issue we plan to publish novel antimicrobials which show activity against resistant strains of bacteria and viruses, essentially working through previously under-appreciated modes of action. We are welcoming high-quality reviews and original research articles which address the present scenario of antimicrobial therapy against pharmaceutically important bacterial pathogens.

Dr. Tejabhiram Yadavalli
Dr. Gopinath Venkatraman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanomaterials
  • drug delivery
  • antiviral resistance
  • antibacterial resistance and mechanism of action

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pathogens - ISSN 2076-0817